Tilray Inc (NASDAQ:TLRY) — Market Cap & Net Worth
Market Cap & Net Worth: Tilray Inc (TLRY)
Tilray Inc (NASDAQ:TLRY) has a market capitalization of $717.68 Million ($717.68 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10720 globally and #2653 in its home market, demonstrating a -11.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tilray Inc's stock price $6.16 by its total outstanding shares 116506916 (116.51 Million). Analyse cash flow conversion of Tilray Inc to see how efficiently the company converts income to cash.
Tilray Inc Market Cap History: 2018 to 2026
Tilray Inc's market capitalization history from 2018 to 2026. Data shows change from $8.22 Billion to $717.68 Million (-15.27% CAGR).
Index Memberships
Tilray Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.03% | #288 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1056 of 3165 |
Weight: Tilray Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tilray Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tilray Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.93x
Tilray Inc's market cap is 0.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $8.22 Billion | $28.63 Million | $22.84 Million | 287.06x | 359.87x |
| 2019 | $2.00 Billion | $179.30 Million | -$25.04 Million | 11.13x | N/A |
| 2020 | $962.35 Million | $405.33 Million | -$102.54 Million | 2.37x | N/A |
| 2021 | $819.04 Million | $619.67 Million | -$443.75 Million | 1.32x | N/A |
| 2022 | $313.40 Million | $792.12 Million | -$601.05 Million | 0.40x | N/A |
| 2023 | $267.97 Million | $844.72 Million | -$1.96 Billion | 0.32x | N/A |
| 2024 | $154.95 Million | $1.07 Billion | -$333.80 Million | 0.14x | N/A |
| 2025 | $1.05 Billion | $1.13 Billion | -$3.00 Billion | 0.93x | N/A |
Competitor Companies of TLRY by Market Capitalization
Companies near Tilray Inc in the global market cap rankings as of May 4, 2026.
Key companies related to Tilray Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
Tilray Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Tilray Inc's market cap moved from $8.22 Billion to $ 717.68 Million, with a yearly change of -15.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $717.68 Million | -31.78% |
| 2025 | $1.05 Billion | +578.95% |
| 2024 | $154.95 Million | -42.17% |
| 2023 | $267.97 Million | -14.50% |
| 2022 | $313.40 Million | -61.74% |
| 2021 | $819.04 Million | -14.89% |
| 2020 | $962.35 Million | -51.78% |
| 2019 | $2.00 Billion | -75.72% |
| 2018 | $8.22 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Tilray Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $717.68 Million USD |
| MoneyControl | $717.68 Million USD |
| MarketWatch | $717.68 Million USD |
| marketcap.company | $717.68 Million USD |
| Reuters | $717.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more